Cargando…
Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction
Bone is one of the most common organs of breast cancer metastasis. Cancer cells that mimic osteoblasts by expressing bone matrix proteins and factors have a higher likelihood of metastasizing to bone. However, the molecular mechanisms of osteomimicry formation of cancer cells remain undefined. Herei...
Autores principales: | Tan, Cong-Cong, Li, Gui-Xi, Tan, Li-Duan, Du, Xin, Li, Xiao-Qing, He, Rui, Wang, Qing-Shan, Feng, Yu-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346745/ https://www.ncbi.nlm.nih.gov/pubmed/27806311 http://dx.doi.org/10.18632/oncotarget.12939 |
Ejemplares similares
-
Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells
por: Absil, L., et al.
Publicado: (2020) -
Gremlin-1 suppression increases BMP-2-induced osteogenesis of human mesenchymal stem cells
por: Hu, Kongzu, et al.
Publicado: (2017) -
The endoplasmic reticulum may be an Achilles' heel of cancer cells that have undergone an epithelial-to-mesenchymal transition
por: Feng, Yu-xiong, et al.
Publicado: (2014) -
Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth
por: Sphyris, Nathalie, et al.
Publicado: (2021) -
Genistein Promotion of Osteogenic Differentiation through BMP2/SMAD5/RUNX2 Signaling
por: Dai, Jin, et al.
Publicado: (2013)